Our Chief Scientific Officer, Dr. Jody Green will be speaking at the upcoming Advancements and Challenges in Abuse Potential Evaluation taking place October 11-12.

Dr. Green’s talk, “Novel approaches to closing the gaps in the current postmarket surveillance mosaic,” will be featured on day two of the event.

About Jody Green, PhD

As Chief Scientific Officer for Inflexxion, Dr. Green provides strategic direction for epidemiologic research design, development and enhancement of public health surveillance networks, and data dissemination activities for post-market studies of prescription drug misuse and abuse. Dr. Green provides thought leadership in the areas of regulatory strategy, epidemiological methods, and drug safety and has extensive experience consulting with pharmaceutical companies in areas of risk management, New Drug Applications (NDAs), as well as advisory committee preparation to address questions related to abuse deterrence, substance abuse and epidemiology studies for prescription medications. Dr. Green is a current member of the Prevention of Overdoses and Treatment Errors in Children Taskforce (PROTECT) of the Centers for Disease Control and Prevention (CDC) which is an assembly of experts to develop strategies to keep children safe from unintentional medication overdoses. She has over 15 years of experience in drug safety surveillance aimed to advance public health and patient safety, authoring or co-authoring over 50 manuscripts in peer-reviewed journals.

Dr. Green received her doctorate in applied statistics and research methods from the University of Northern Colorado in 2000. Prior to joining Inflexxion she was the Director of Research at the Rocky Mountain Poison and Drug Center in Denver, Colorado, where she was the principal investigator on over 40 studies ranging from clinical trials to observational studies, primarily focused on pharmaceutical and consumer product safety. She was an adjunct Assistant Professor of Nursing (Research) at Vanderbilt University School of Nursing from 2007 to 2011. She is the Past-President of the Society of Clinical Research Associates (SoCRA).